发明名称 MUSCARINIC AGONISTS
摘要 FIELD: organic chemistry, medicine. ^ SUBSTANCE: invention relates to compounds of the general formula (I): wherein Z1 represents -CR1 or nitrogen atom (N); Z2 represents -CR2; Z3 represents -CR3 or N; Z4 represents -CR4; W1 represents oxygen (O), sulfur (S) atom or -NR5; one of W2 and W3 represents N or -CR6 and another among W2 and W3 represents CG; W1 represents NG; W2 represents -CR5 or N; W3 represents -CR6 or N; or W1 and W3 represent N and W2 represents NG; G represents compound of the formula (II): wherein Y represents oxygen atom (O), -C(O)- or absent; p = 1, 2, 3, 4 or 5; Z is absent; each t = 2. Also, invention describes a method for enhancing activity of the muscarinic cholinergic receptor and a method for treatment of morbid states when modification of cholinergic and, especially, muscarinic receptors m1, m4 or both m1 and m4 offers the favorable effect. ^ EFFECT: valuable medicinal properties of agonists. ^ 14 cl, 2 tbl, 101 ex
申请公布号 RU2269523(C2) 申请公布日期 2006.02.10
申请号 RU20020131937 申请日期 2001.04.27
申请人 发明人 ANDERSSON KARL-MAGNUS A.;FRIBERG BO LENNART M.;SK'JAERBAEK NIL'S;SPEHLDING TREJSI;JULDEHM ALLAN K.
分类号 C07D249/18;C07D401/06;A61K31/4439;A61K31/454;A61K31/52;A61P25/02;A61P25/04;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/24;A61P25/28;A61P27/06;C07C271/28;C07D261/20;C07D333/54;C07D405/06;C07D407/04;C07D409/04;C07D409/06;C07D413/06;C07D413/12;C07D417/06;C07D471/04;C07D473/00;C07D487/04;C07F7/22 主分类号 C07D249/18
代理机构 代理人
主权项
地址